Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Effectiveness study (incl. comparative)

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Observational study, Review of electronic case report forms
Study drug and medical condition

Medical condition to be studied

Fungal infection
Acute myeloid leukaemia
Acute lymphocytic leukaemia
Population studied

Short description of the study population

Patients with hematological malignancies (HMs, acute myeloid leukemia or acute lymphoid leukemia) admitted to Italian hematology wards.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Hematological malignancies patients

Estimated number of subjects

1000
Study design details

Main study objective

To estimate the rate of occurrence of possible, probable, and proven IFDs in patients affected by newly diagnosed HMs (acute myeloid leukemia or acute lymphoid leukemia) admitted to hematology wards in Italy.

Outcomes

Rate of occurrence of possible, probable, and proved IFDs.

Data analysis plan

No formal statistical hypotheses will be tested, only descriptive statistics will be calculated. The analysis to assess the outcomes of patients with suspected fungal-related febrile events will be performed using standard survival analysis methods, including Kaplan-Meier product-limit survival curve estimates and log-rank tests for comparison between groups.
Documents
Study results
English (2.18 MB - PDF)View document